Hikma Pharmaceuticals (HIK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,785.00p
   
  • Change Today:
    -30.00p
  • 52 Week High: 2,340.00p
  • 52 Week Low: 1,740.00p
  • Currency: UK Pounds
  • Shares Issued: 221.89m
  • Volume: 497,913
  • Market Cap: £3,960.67m
  • RiskGrade: 125

Regulatory News

Director/PDMR Shareholding 22-Aug-2025 12:02 RNS
Director/PDMR Shareholding 13-Aug-2025 13:51 RNS
Director/PDMR Shareholding 08-Aug-2025 12:59 RNS
Half-year Report 07-Aug-2025 07:00 RNS
Notice of Results 09-Jul-2025 09:00 RNS
Publication of Offering Circular 07-Jul-2025 09:16 RNS
Director/PDMR Shareholding 09-Jun-2025 15:33 RNS
Director/PDMR Shareholding 05-Jun-2025 14:05 RNS
Director/PDMR Shareholding 03-Jun-2025 13:02 RNS
Fitch upgrades Hikma to ‘BBB’ 29-May-2025 07:00 RNS
Director/PDMR Shareholding 20-May-2025 14:49 RNS
Medium-term Group guidance ahead of US site visit 15-May-2025 12:00 RNS
Director/PDMR Shareholding 08-May-2025 16:35 RNS
S&P upgrades Hikma to ‘BBB’ 08-May-2025 10:48 RNS
Settlement agreement for Xyrem® US lawsuits 08-May-2025 08:21 RNS
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

HIK Market Data

Currency UK Pounds
Share Price 1,785.00p
Change Today -30.00p
% Change -1.65 %
52 Week High 2,340.00p
52 Week Low 1,740.00p
Volume 497,913
Shares Issued 221.89m
Market Cap £3,960.67m
RiskGrade 125

HIK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
74.3% below the market average74.3% below the market average74.3% below the market average74.3% below the market average74.3% below the market average
31.71% above the sector average31.71% above the sector average31.71% above the sector average31.71% above the sector average31.71% above the sector average
Price Trend
51.95% below the market average51.95% below the market average51.95% below the market average51.95% below the market average51.95% below the market average
13.64% above the sector average13.64% above the sector average13.64% above the sector average13.64% above the sector average13.64% above the sector average
Income
38.55% above the market average38.55% above the market average38.55% above the market average38.55% above the market average38.55% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
42.16% above the market average42.16% above the market average42.16% above the market average42.16% above the market average42.16% above the market average
3.45% above the sector average3.45% above the sector average3.45% above the sector average3.45% above the sector average3.45% above the sector average

What The Brokers Say

Strong Buy 6
Buy 3
Neutral 3
Sell 0
Strong Sell 0
Total 12
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

HIK Dividends

  Latest Previous
  Interim Final
Ex-Div 14-Aug-25 20-Mar-25
Paid 18-Sep-25 01-May-25
Amount 36.00¢ 48.00¢

Trades for 29-Aug-2025

Time Volume / Share Price
16:35 535 @ 1,785.00p
16:35 407 @ 1,785.00p
16:35 1,342 @ 1,785.00p
16:35 358,945 @ 1,785.00p
16:35 3,816 @ 1,785.00p

HIK Key Personnel

CEO Riad Mishlawi

Top of Page